Clinical Trials

Showing trials with last updates posted in 2026.

NCT05231122 | RECRUITING | PHASE2
80 participants

Pembrolizumab Combined With Bevacizumab With or Without Agonist Anti-CD40 CDX-1140 for the Treatment of Patients With Recurrent Ovarian Cancer

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-14
Start Date:
2024-03-12
Completion:
2027-03-15
Conditions
  • Ovarian Clear Cell Adenocarcinoma
  • Platinum-Sensitive Ovarian Carcinoma
  • Recurrent Endometrial Serous Adenocarcinoma
  • Recurrent Fallopian Tube Carcinoma
  • Recurrent Fallopian Tube Endometrioid Adenocarcinoma
  • Recurrent Fallopian Tube Serous Adenocarcinoma
  • Recurrent Ovarian Carcinoma
  • Recurrent Ovarian Clear Cell Adenocarcinoma
  • Recurrent Ovarian Endometrioid Adenocarcinoma
  • Recurrent Ovarian Serous Adenocarcinoma
  • Recurrent Platinum-Resistant Ovarian Carcinoma
  • Recurrent Primary Peritoneal Carcinoma
  • Recurrent Primary Peritoneal Clear Cell Adenocarcinoma
  • Recurrent Primary Peritoneal Endometrioid Adenocarcinoma
  • Recurrent Primary Peritoneal Serous Adenocarcinoma
Interventions
  • BIOLOGICAL
  • OTHER
No Results Yet
NCT05025059 | ACTIVE_NOT_RECRUITING | NA
30 participants

Exercise During Chemotherapy in Older Women With Stage I-III Breast Cancer

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-14
Start Date:
2020-12-03
Completion:
2026-12-31
Conditions
  • Anatomic Stage I Breast Cancer AJCC v8
  • Anatomic Stage IA Breast Cancer AJCC v8
  • Anatomic Stage IB Breast Cancer AJCC v8
  • Anatomic Stage II Breast Cancer AJCC v8
  • Anatomic Stage IIA Breast Cancer AJCC v8
  • Anatomic Stage IIB Breast Cancer AJCC v8
  • Anatomic Stage III Breast Cancer AJCC v8
  • Anatomic Stage IIIA Breast Cancer AJCC v8
  • Anatomic Stage IIIB Breast Cancer AJCC v8
  • Anatomic Stage IIIC Breast Cancer AJCC v8
  • Prognostic Stage I Breast Cancer AJCC v8
  • Prognostic Stage IA Breast Cancer AJCC v8
  • Prognostic Stage IB Breast Cancer AJCC v8
  • Prognostic Stage II Breast Cancer AJCC v8
  • Prognostic Stage IIA Breast Cancer AJCC v8
  • Prognostic Stage IIB Breast Cancer AJCC v8
  • Prognostic Stage III Breast Cancer AJCC v8
  • Prognostic Stage IIIA Breast Cancer AJCC v8
  • Prognostic Stage IIIB Breast Cancer AJCC v8
  • Prognostic Stage IIIC Breast Cancer AJCC v8
Interventions
  • PROCEDURE
  • OTHER
No Results Yet
NCT04969081 | ACTIVE_NOT_RECRUITING | NA
103 participants

Impact of Work Activity on SUD Outcomes

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-14
Start Date:
2022-01-03
Completion:
2027-12-31
Conditions
  • Substance-related Disorders
Interventions
  • BEHAVIORAL
  • OTHER
No Results Yet
NCT04920344 | ACTIVE_NOT_RECRUITING | PHASE2
15 participants

Swallowing Outcomes and Circulating Tumor DNA in Patients With HPV Related Oropharyngeal Cancer Treated With Transoral Surgery and Reduced Intensity Adjuvant Therapy

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-14
Start Date:
2021-05-19
Completion:
2026-05-30
Conditions
  • Clinical Stage I HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8
  • Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8
  • Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8
  • Oropharyngeal Human Papillomavirus-Positive Squamous Cell Carcinoma
Interventions
  • PROCEDURE
  • RADIATION
  • DRUG
  • OTHER
  • DIAGNOSTIC_TEST
No Results Yet
NCT04825782 | COMPLETED
15391 participants

MiMBa Pregnancy Registry

Study Type:
OBSERVATIONAL
Last Updated:
2026-08-14
Start Date:
2021-02-22
Completion:
2025-12-31
Conditions
  • Malaria in Pregnancy
  • Pregnancy Related
  • Congenital Anomaly
No Results Yet
Previous
Sorted by latest updates
Next
Showing 40 trials per page